These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 2212994)
1. Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. Patick AK; Oleszak EL; Leibowitz JL; Rodriguez M J Gen Virol; 1990 Sep; 71 ( Pt 9)():2123-32. PubMed ID: 2212994 [TBL] [Abstract][Full Text] [Related]
2. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926 [TBL] [Abstract][Full Text] [Related]
3. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. Lipton HL J Gen Virol; 1980 Jan; 46(1):169-77. PubMed ID: 6243340 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain). Oleszak EL; Leibowitz JL; Rodriguez M J Gen Virol; 1988 Sep; 69 ( Pt 9)():2413-8. PubMed ID: 2842440 [TBL] [Abstract][Full Text] [Related]
5. Strains from both Theiler's virus subgroups encode a determinant for demyelination. Fu J; Rodriguez M; Roos RP J Virol; 1990 Dec; 64(12):6345-8. PubMed ID: 2243399 [TBL] [Abstract][Full Text] [Related]
6. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. Gerety SJ; Rundell MK; Dal Canto MC; Miller SD J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740 [TBL] [Abstract][Full Text] [Related]
11. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. Zurbriggen A; Fujinami RS J Virol; 1989 Apr; 63(4):1505-13. PubMed ID: 2538641 [TBL] [Abstract][Full Text] [Related]
12. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice. Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. Lindsley MD; Rodriguez M J Immunol; 1989 Apr; 142(8):2677-82. PubMed ID: 2495323 [TBL] [Abstract][Full Text] [Related]
14. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327 [TBL] [Abstract][Full Text] [Related]
15. Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. Zurbriggen A; Yamada M; Thomas C; Fujinami RS J Virol; 1991 Feb; 65(2):1023-30. PubMed ID: 1987366 [TBL] [Abstract][Full Text] [Related]
16. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Pullen LC; Miller SD; Dal Canto MC; Kim BS Eur J Immunol; 1993 Sep; 23(9):2287-93. PubMed ID: 8370406 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. Rodriguez M; Lucchinetti CF; Clark RJ; Yakash TL; Markowitz H; Lennon VA J Immunol; 1988 Feb; 140(3):800-6. PubMed ID: 3339243 [TBL] [Abstract][Full Text] [Related]
18. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446 [TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. Patick AK; Pease LR; David CS; Rodriguez M J Virol; 1990 Nov; 64(11):5570-6. PubMed ID: 2214025 [TBL] [Abstract][Full Text] [Related]
20. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. Welsh CJ; Tonks P; Nash AA; Blakemore WF J Gen Virol; 1987 Jun; 68 ( Pt 6)():1659-67. PubMed ID: 2953860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]